[Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential]
- PMID: 22875694
- DOI: 10.1055/s-0032-1305216
[Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential]
Abstract
Uncontrolled electrical activity caused by ion channel dysfunction produces arrhythmia in the heart. Despite recent advances in pharmaceutical research and development, effective and safe pharmacological management of cardiac arrhythmia still remains an unmet medical need. The emerging family of two-pore-domain potassium (K2P) channels stabilizes the resting membrane potential and facilitates action potential repolarization. In the heart, genetic inactivation or inhibition of two-pore-domain K + (K2P) currents by class III antiarrhythmic drugs results in action potential prolongation. In particular, human K2P3.1 channels are selectively expressed in the atria and represent targets for the pharmacological management of atrial fibrillation. Furthermore, stretch-sensitive K2P2.1 channels are implicated in mechanoelectrical feedback and arrhythmogenesis. The current knowledge on function, regulation, and cardiac significance of K2P channels is summarized in this work, and potential therapeutic implications are highlighted.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.Eur J Pharmacol. 2014 Sep 5;738:250-5. doi: 10.1016/j.ejphar.2014.05.056. Epub 2014 Jun 10. Eur J Pharmacol. 2014. PMID: 24927994 Review.
-
Pharmacology of cardiac potassium channels.Adv Pharmacol. 2010;59:93-134. doi: 10.1016/S1054-3589(10)59004-5. Adv Pharmacol. 2010. PMID: 20933200 Review.
-
Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine model.Life Sci. 2014 Mar 3;97(2):107-15. doi: 10.1016/j.lfs.2013.12.006. Epub 2013 Dec 15. Life Sci. 2014. PMID: 24345461
-
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9. Basic Res Cardiol. 2018. PMID: 29881975
-
Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.Biochem Biophys Res Commun. 2014 Aug 29;451(3):415-20. doi: 10.1016/j.bbrc.2014.07.133. Epub 2014 Aug 7. Biochem Biophys Res Commun. 2014. PMID: 25108155
Cited by
-
Pulmonary epithelial barrier function: some new players and mechanisms.Am J Physiol Lung Cell Mol Physiol. 2015 Apr 15;308(8):L731-45. doi: 10.1152/ajplung.00309.2014. Epub 2015 Jan 30. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 25637609 Free PMC article. Review.
-
New Strategies for the Treatment of Atrial Fibrillation.Pharmaceuticals (Basel). 2021 Sep 15;14(9):926. doi: 10.3390/ph14090926. Pharmaceuticals (Basel). 2021. PMID: 34577626 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
